Rocket Lab: A $17 Billion Contract Expansion Meets a Market in Retreat
Published on 07/21/2026 at 18:12 | Redaktion boerse-global.de
A massive contract upgrade from the U.S. Space Force should have been unambiguously good news for Rocket Lab. But on Monday, the stock fell anyway, dragged lower by a heavier weight: a sector-wide rotation, a blockbuster acquisition, and a delayed rocket program. Only a day later did the market begin to reassess.
The Space Force slapped an extra $11.4 billion on the ceiling of its National Security Space Launch Phase 3 Lane 1 contract vehicle, raising the maximum value from $5.6 billion to $17 billion. Seven companies — including Rocket Lab, SpaceX, Blue Origin, and United Launch Alliance — can now compete for a far larger pool of launch orders through fiscal year 2029. Rocket Lab only joined the program in 2024 with its upcoming Neutron rocket, and the cap increase does not guarantee revenue: each mission still requires a competitive bid and certification of flight readiness.
The announcement, dated July 17, initially failed to lift the stock. Shares closed Monday down 2.7% at $65.74, a three-month low. Retail investors on Stocktwits, however, spotted a buying opportunity, labeling sentiment "bullish" on elevated message volume. By Tuesday, the equity had bounced 4.7% to $68.83.
That modest recovery belies a far deeper slump. Rocket Lab’s stock now sits 54% below its 52-week high of $151 reached in late May, and has lost 31% over the past 30 days. The relative strength index (RSI) has dropped to 29.1, deep in oversold territory, though analysts caution that even at these levels the shares trade at 31 times projected 2027 revenue.
Should investors sell immediately? Or is it worth buying Rocket Lab USA?
The sell-off is the product of three shocks hitting simultaneously. First, Rocket Lab announced a binding agreement to acquire Iridium Communications in an $8 billion deal. Iridium shareholders will receive $54 per share. For Rocket Lab, the acquisition promises vertical integration in space communications — but the market balked at the dilution risk to existing shareholders.
Second, the first flight of the Neutron rocket has slipped to the fourth quarter of 2026, pushing a key catalyst further into the future. Third, CEO Peter Beck conducted pre-planned stock sales in early July under a 10b5-1 trading program, offloading shares at prices between roughly $82 and $102. Any one of these events might have been manageable. Together they landed on a sector already under pressure from the much-hyped initial public offering of rival SpaceX earlier this year.
The broader space industry has been in retreat since that IPO. Rocket Lab, which had surged more than 150% in the prior twelve months, has been a bellwether for the downturn. The stock has given back 56% from its May peak, though it remains up about 39% year-over-year. On a year-to-date basis, however, the equity is down nearly 6% — a sharp reversal from its spring highs.
Revenue growth remains a bright spot. Rocket Lab generated $680 million in sales over the trailing twelve months, a tenfold increase from five years ago. The Iridium target brings in $871 million annually, more than Rocket Lab’s entire existing business. Skeptics counter that even after the 56% drawdown, the stock’s forward revenue multiple (31x for 2027) leaves little margin for error. For comparison, rival AST SpaceMobile trades at 42x, but its entire thesis rests on a single technology; Rocket Lab’s business spans launch services, spacecraft systems, and defense contracts.
Rocket Lab USA at a turning point? This analysis reveals what investors need to know now.
The retail investor base on Reddit has tracked the mood swings precisely. Sentiment hit a peak of 85 on a sentiment scale around the Iridium announcement, then cratered to between 18 and 24 by mid-July. Yet many individual holders continue to defend the long-term growth story, even as the stock price disintegrates.
Ultimately, Neutron’s fate will determine the narrative. A clean first launch would validate Rocket Lab as a genuine challenger to SpaceX; any further tank-test failures would delay the timeline again. In the near term, investors are watching for progress on Neutron testing and details on how Rocket Lab plans to finance the Iridium acquisition. With an annualized volatility of roughly 96%, the stock demands patience — and a strong stomach.
Ad
Rocket Lab USA Stock: New Analysis - 21 July
Fresh Rocket Lab USA information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
